Search Our Scientific Publications & Authors

Publications
find publications by category +
Translate page:

An AICD-based functional screen to identify APP metabolism regulators.

Authors:
Can Zhang Preeti J Khandelwal Ranjita Chakraborty Trinna L Cuellar Srikant Sarangi Shyam A Patel Christopher P Cosentino Michael O'Connor Jeremy C Lee Rudolph E Tanzi Aleister J Saunders

Mol Neurodegener 2007 Aug 24;2:15. Epub 2007 Aug 24.

Department of Bioscience & Biotechnology, Drexel University, Philadelphia, PA, USA.

Background: A central event in Alzheimer's disease (AD) is the regulated intramembraneous proteolysis of the beta-amyloid precursor protein (APP), to generate the beta-amyloid (Abeta) peptide and the APP intracellular domain (AICD). Abeta is the major component of amyloid plaques and AICD displays transcriptional activation properties. We have taken advantage of AICD transactivation properties to develop a genetic screen to identify regulators of APP metabolism. This screen relies on an APP-Gal4 fusion protein, which upon normal proteolysis, produces AICD-Gal4. Production of AICD-Gal4 induces Gal4-UAS driven luciferase expression. Therefore, when regulators of APP metabolism are modulated, luciferase expression is altered.

Results: To validate this experimental approach we modulated alpha-, beta-, and gamma-secretase levels and activities. Changes in AICD-Gal4 levels as measured by Western blot analysis were strongly and significantly correlated to the observed changes in AICD-Gal4 mediated luciferase activity. To determine if a known regulator of APP trafficking/maturation and Presenilin1 endoproteolysis could be detected using the AICD-Gal4 mediated luciferase assay, we knocked-down Ubiquilin 1 and observed decreased luciferase activity. We confirmed that Ubiquilin 1 modulated AICD-Gal4 levels by Western blot analysis and also observed that Ubiquilin 1 modulated total APP levels, the ratio of mature to immature APP, as well as PS1 endoproteolysis.

Conclusion: Taken together, we have shown that this screen can identify known APP metabolism regulators that control proteolysis, intracellular trafficking, maturation and levels of APP and its proteolytic products. We demonstrate for the first time that Ubiquilin 1 regulates APP metabolism in the human neuroblastoma cell line, SH-SY5Y.

Download full-text PDF

 Source
http://dx.doi.org/10.1186/1750-1326-2-15DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2071909PMC
August 2007

Publication Analysis

Top Keywords

app metabolism
20
screen identify
12
app
11
metabolism regulators
8
blot analysis
8
aicd-gal4 mediated
8
luciferase activity
8
mediated luciferase
8
regulators app
8
western blot
8
ubiquilin modulated
8
luciferase expression
8
changes aicd-gal4
8
aicd-gal4 levels
8
identify app
8
aicd-gal4
6
levels
5
luciferase
5
metabolism
5
proteolysis intracellular
4

Keyword Occurance

Similar Publications

Improving insulin sensitivity, liver steatosis and fibrosis in type 2 diabetes by a food-based digital education-assisted lifestyle intervention program: a feasibility study.

Authors:
Oana P Zaharia Yuliya Kupriyanova Yanislava Karusheva Daniel F Markgraf Konstantinos Kantartzis Andreas L Birkenfeld Michael Trenell Aarti Sahasranaman Chris Cheyette Theresa Kössler Kálmán Bódis Volker Burkart Jong-Hee Hwang Michael Roden Julia Szendroedi Dominik H Pesta

Eur J Nutr 2021 Apr 11. Epub 2021 Apr 11.

Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University, Düsseldorf, Germany.

Purpose: Recent trials demonstrated remission of type 2 diabetes and non-alcoholic fatty liver disease (NAFLD) following formula diet-induced weight loss. To improve the outreach for populations in need, many mobile health apps targeting weight loss have been developed with limited scientific evaluation of these apps. The present feasibility study investigated the effects of a novel approach incorporating a regular 'whole food-based' low-calorie diet combined with app-based digital education and behavioral change program on glucose metabolism and disease management. Read More

View Article and Full-Text PDF
April 2021
Similar Publications

There is detectable variation in the lipidomic profile between stable and progressive patients with idiopathic pulmonary fibrosis (IPF).

Authors:
Shabarinath Nambiar Britt Clynick Bong S How Adam King E Haydn Walters Nicole S Goh Tamera J Corte Robert Trengove Dino Tan Yuben Moodley

Respir Res 2021 Apr 9;22(1):105. Epub 2021 Apr 9.

School of Biomedical Science, University of Western Australia, Crawley, WA, Australia.

Background: Idiopathic pulmonary fibrosis (IPF) is a chronic interstitial lung disease characterized by fibrosis and progressive loss of lung function. The pathophysiological pathways involved in IPF are not well understood. Abnormal lipid metabolism has been described in various other chronic lung diseases including asthma and chronic obstructive pulmonary disease (COPD). Read More

View Article and Full-Text PDF
April 2021
Similar Publications

Executive Functioning, Depressive Symptoms, and Intervention Engagement in a Sample of Adolescents Enrolled in a Weight Management Program.

Authors:
Kelleen E Lopez Sarah-Jeanne Salvy Cassandra Fink Julie Werner Choo Phei Wee Elizabeth Hegedus Janelle Gonzalez D Steven Fox Alaina P Vidmar

Child Obes 2021 Apr 7. Epub 2021 Apr 7.

Diabetes and Obesity Program, Center for Endocrinology, Diabetes, and Metabolism, Children's Hospital Los Angeles, Los Angeles, CA, USA.

This study examines how baseline demographics, psychosocial characteristics, and intervention delivery predict engagement among adolescents with overweight and obesity seeking treatment. Data originates from a multisite randomized control trial evaluating the efficacy of an app-based weight loss intervention, compared with standard in-clinic model in adolescents with overweight and obesity. Participants were randomized to one of the three arms: (1) AppCoach, (2) AppAlone, or (3) Control. Read More

View Article and Full-Text PDF
April 2021
Similar Publications

The neuroprotection of deproteinized calf blood extractives injection against Alzheimer's disease via regulation of Nrf-2 signaling.

Authors:
Yidi Qu Wenqi Wang Tianrui Chen Yumin Yang Yizhi Zhang Di Wang

Aging (Albany NY) 2021 Mar 26;13. Epub 2021 Mar 26.

School of Life Sciences, Jilin University, Changchun 130012, China.

Alzheimer's disease (AD) is characterized by cognitive decline due to the accumulation of extracellular β-amyloid (Aβ) plaques and neurofibrillary tangles in the brain, which impair glutamate (Glu) metabolism. Deproteinized Calf Blood Extractive Injection (DCBEI) is a biopharmaceutical that contains 17 types of amino acids and 5 types of nucleotides. In this study, we found that DCBEI pretreatment reduced L-Glu-dependent neuroexcitation toxicity by maintaining normal mitochondrial function in HT22 cells. Read More

View Article and Full-Text PDF
March 2021
Similar Publications

Dynamic Change of Intracellular Metabolism of Microglia Evaluated by Transcriptomics in an Alzheimer's Mouse Model.

Authors:
Hongyan Qiu Ruoqi Zhao Guoqiang Fei Xiaoli Pan Shaoming Sang Yangqi Xu Boru Jin Lirong Jin Xiaoqin Cheng Chunjiu Zhong

J Alzheimers Dis 2021 Mar 30. Epub 2021 Mar 30.

Department of Neurology, Zhongshan Hospital; State Key Laboratory of Medical Neurobiology; Institutes of Brain Science; Fudan University, Shanghai, China.

Background: Microglia play diverse roles in Alzheimer's disease (AD). Intracellular metabolism has been indicated an important factor in modulating the function of microglia. However, it is not clear whether the intracellular metabolism of microglia changes dynamically in different stages of AD. Read More

View Article and Full-Text PDF
March 2021
Similar Publications